GoodRx Holdings, Inc. (GDRX)
Automate Your Wheel Strategy on GDRX
With Tiblio's Option Bot, you can configure your own wheel strategy including GDRX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol GDRX
- Rev/Share 2.1029
- Book/Share 1.7256
- PB 2.2717
- Debt/Equity 0.0846
- CurrentRatio 5.2253
- ROIC 0.057
- MktCap 1400103146.0
- FreeCF/Share 0.2659
- PFCF 13.8837
- PE 30.9825
- Debt/Assets 0.0427
- DivYield 0
- ROE 0.0699
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 4
- P/B Score 2
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | GDRX | Mizuho | -- | Neutral | -- | $5 | Dec. 4, 2024 |
News
Buy 5 Health and Fitness Stocks to Enhance Your Portfolio Returns
Published: May 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Five Health and Fitness stocks to buy now are: SFM, DXCM, HIMS, UNFI, GDRX.
Read More
GDRX vs. PGNY: Which Stock Should Value Investors Buy Now?
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for stocks in the Medical Services sector might want to consider either GoodRx Holdings, Inc. (GDRX) or Progyny (PGNY). But which of these two stocks is more attractive to value investors?
Read More
GoodRx Holdings, Inc. (GDRX) Q1 2025 Earnings Call Transcript
Published: May 08, 2025 by: Seeking Alpha
Sentiment: Neutral
GoodRx Holdings, Inc. (NASDAQ:GDRX ) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Aubrey Reynolds – Director-Investor Relations Wendy Barnes – President and Chief Executive Officer Chris McGinnis – Chief Financial Officer Conference Call Participants Lisa Gill – JPMorgan John Ransom – RJF Charles Rhyee – TD Cowen Jailendra Singh – Truist Securities Craig Hettenbach – Morgan Stanley George Hill – Deutsche Bank Steven Valiquette – Mizuho Securities Allen Lutz – Bank of America Michael Cherny – Leerink Partners Daniel Grosslight – Citi Operator Ladies and gentlemen, thank you for standing by and welcome to …
Read More
Is GoodRx (GDRX) a Great Value Stock Right Now?
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Compared to Estimates, GoodRx (GDRX) Q1 Earnings: A Look at Key Metrics
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for GoodRx (GDRX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
GoodRx Holdings, Inc. (GDRX) Q1 Earnings Match Estimates
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive
GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.09 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.08 per share a year ago.
Read More
GoodRx Stock Tumbles Despite Launching New Retail Pharmacy Platform
Published: April 08, 2025 by: Zacks Investment Research
Sentiment: Neutral
GDRX rolls out a new e-commerce platform connecting users to top retail pharmacies, aiming to boost savings, improve access, and expand its digital health services.
Read More
GoodRx Report Reveals Striking Gender Divide in Prescription Medication Spending
Published: March 10, 2025 by: Business Wire
Sentiment: Neutral
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today released a new report, The Prescription Drug Gender Divide, detailing how women shoulder a significantly greater out-of-pocket cost burden than men. The data shows that in 2024, women spent $8.8 billion – or 30% – more than men on out-of-pocket prescription costs. Combined with the common responsibilities of managing a career, family planning, and caregiving, women are le.
Read More
GoodRx Reports Mixed Q4: Pharma Strength Amid Subscription Decline, Sluggish Prescription Sales
Published: February 27, 2025 by: Benzinga
Sentiment: Neutral
GoodRx Holdings Inc. GDRX reported fourth-quarter revenue of $198.6 million, up slightly by 1% year over year, missing the management guidance of around $200 million and consensus of $199.75 million.
Read More
GoodRx Holdings, Inc. (GDRX) Q4 2024 Earnings Call Transcript
Published: February 27, 2025 by: Seeking Alpha
Sentiment: Neutral
GoodRx Holdings, Inc. (NASDAQ:GDRX ) Q4 2024 Earnings Conference Call February 27, 2025 8:00 AM ET Company Participants Aubrey Reynolds - Director, IR Wendy Barnes - CEO Chris McGinnis - CFO Conference Call Participants Lisa Gill - J.P. Morgan John Ransom - RJF Charles Rhyee - TD Cowen Michael Cherny - Leerink Partners Jenny Cao - Truist Scott Schoenhaus - KeyBanc Stan Berenshteyn - Wells Fargo Securities Steven Valiquette - Mizuho Securities Jay Jin - Morgan Stanley George Hill - Deutsche Bank Allen Lutz - Bank of America Operator Ladies and gentlemen, thank you for standing by, and welcome to …
Read More
About GoodRx Holdings, Inc. (GDRX)
- IPO Date 2020-09-23
- Website https://www.goodrx.com
- Industry Medical - Healthcare Information Services
- CEO Ms. Wendy Barnes
- Employees 738